Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/cgt201292.pdf
Reference46 articles.
1. Cattaneo R, Miest T, Shashkova EV, Barry MA . Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol 2008; 6: 529–540.
2. Liu TC, Galanis E, Kirn D . Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol 2007; 4: 101–117.
3. Garber K . China approves world’s first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst 2006; 98: 298–300.
4. Parks R, Evelegh C, Graham F . Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Therapy 1999; 6: 1565–1573.
5. Rose JK, Bergmann JE . Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell 1983; 34: 513–524.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy;Journal of Translational Medicine;2023-07-25
2. Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment;Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs);2023
3. Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene;Molecular Therapy - Methods & Clinical Development;2022-09
4. Robust envelope exchange platform for oncolytic measles virus;Journal of Virological Methods;2022-04
5. In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand;Molecular Therapy - Methods & Clinical Development;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3